Anyway it's the clinicians who will decide which one to use in each case.
No one is going to take the whole market like rabid sycophants like ass11 would have us believe.
The information I pay attention to is the doctor who says it would be used in half of his patients.
There's obviously a reason why he didn't say all of them.
As for supply constraints with copper; there's likely some truth in that but of course those associated with the company will downplay that and competitors will be hyper critical.
Relative cost is another factor in how things play out.
I see $30-$40 in value for prostate imaging alone when in the market and mature but I'm just a pleb.
Still a ways to go yet though and a pretty hefty MC right now. We should all be very happy with the gains thus far.
CU6 - Media and Industry News, page-434
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.72 |
Change
-0.170(2.47%) |
Mkt cap ! $2.119B | |||
| Open | High | Low | Value | Volume |
| $6.95 | $7.25 | $6.68 | $28.33M | 4.127M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6509 | $6.72 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.78 | 6841 | 1 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |